Alport syndrome differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
According to expert opinion<ref name="pmid23349312">{{cite journal| author=Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F| title=Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. | journal=J Am Soc Nephrol | year= 2013 | volume= 24 | issue= 3 | pages= 364-75 | pmid=23349312 | doi=10.1681/ASN.2012020148 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23349312 }} </ref>, the differential diagnosis of Alport’s syndrome is very wide and includes the following: | According to expert opinion<ref name="pmid23349312">{{cite journal| author=Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F| title=Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. | journal=J Am Soc Nephrol | year= 2013 | volume= 24 | issue= 3 | pages= 364-75 | pmid=23349312 | doi=10.1681/ASN.2012020148 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23349312 }} </ref>, the differential diagnosis of Alport’s syndrome is very wide and includes the following: | ||
===Familial Hematuria=== | |||
*TBMN | *TBMN | ||
* Familial IgA nephropathy | * Familial IgA nephropathy | ||
| Line 23: | Line 23: | ||
* Familial hypercalciuria or familial urolithiasis | * Familial hypercalciuria or familial urolithiasis | ||
===Renal Impairment and Hearing Loss=== | |||
* MYH-9 related disorders such as Fechtner syndrome | * MYH-9 related disorders such as Fechtner syndrome | ||
| Line 49: | Line 49: | ||
* Muckle-Wells syndrome | * Muckle-Wells syndrome | ||
===Hearing Loss=== | |||
* Middle-ear infections | * Middle-ear infections | ||
| Line 64: | Line 64: | ||
* C3 nephropathy | * C3 nephropathy | ||
===Lamellated Glomerular Basement Membrane=== | |||
* Focal damage | * Focal damage | ||
* MYH9-related disorders, such as Fechtner and Epstein syndromes | * MYH9-related disorders, such as Fechtner and Epstein syndromes | ||
Revision as of 19:53, 31 October 2013
|
Alport syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Alport syndrome differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Alport syndrome differential diagnosis |
|
Risk calculators and risk factors for Alport syndrome differential diagnosis |
The differential diagnosis of Alport’s syndrome includes other conditions that involve persistent familial hematuria, renal failure, hearing loss, retinal fleck, and lamellated GBM.[1]Some of the other diseases are listed in the table below.[2][3][4][5][6]
According to expert opinion[1], the differential diagnosis of Alport’s syndrome is very wide and includes the following:
Familial Hematuria
- TBMN
- Familial IgA nephropathy
- MYH9-related disorder, such as Fechtner and Epstein syndromes
- Membranoproliferative GN type 2
- Familail hemolytic uremic syndrome
- C3 nephropathy
- ADPKD
- Sickle cell disease or trait
- Familial hypercalciuria or familial urolithiasis
Renal Impairment and Hearing Loss
- MYH-9 related disorders such as Fechtner syndrome
- Nephronophthisis
- Bartter syndrome
- Distal renal tubular acidosis
- MELAS syndrome
- Fabry disease
- Branchio-oto-renal syndrome
- Townes-Brock syndrome
- CHARGE syndrome
- Kallmann syndrome
- Alstrom disease
- Muckle-Wells syndrome
Hearing Loss
- Middle-ear infections
- Age
- Industrial noise exposure
- Ototoxic drugs
- Renal failure and dialysis
- Retinal flecks (23349312):
- Membranoproliferative GN type 2
- IgA nephropathy
- Systemic lupus erythematosus
- Other forms of GN
- Severe hypertension
- C3 nephropathy
Lamellated Glomerular Basement Membrane
- Focal damage
- MYH9-related disorders, such as Fechtner and Epstein syndromes
- Pierson syndrome
- Nail-patella syndrome
- Mutations in the tetraspanin (CD151) gene
- Frasier syndrome
- Galloway-Mowat syndrome
References
- ↑ 1.0 1.1 Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F (2013). "Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy". J Am Soc Nephrol. 24 (3): 364–75. doi:10.1681/ASN.2012020148. PMID 23349312.
- ↑ Hudson BG, Reeders ST, Tryggvason K (1993). "Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis". J Biol Chem. 268 (35): 26033–6. PMID 8253711.
- ↑ Amari F, Segawa K, Ando F (1994). "Lens coloboma and Alport-like glomerulonephritis". Eur J Ophthalmol. 4 (3): 181–3. PMID 7819734.
- ↑ Lonsdale RN, Roberts PF, Vaughan R, Thiru S (1992). "Familial oesophageal leiomyomatosis and nephropathy". Histopathology. 20 (2): 127–33. PMID 1559666.
- ↑ García-Torres R, Orozco L (1993). "Alport-leiomyomatosis syndrome: an update". Am J Kidney Dis. 22 (5): 641–8. PMID 8238008.
- ↑ McCarthy PA, Maino DM (2000). "Alport syndrome: a review". Clin Eye Vis Care. 12 (3–4): 139–150. PMID 11137428.